Chapter 1. Introduction (2025-2033)
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (2025-2033)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary (2025-2033)
3.1. Market Snapshot
Chapter 4. Market Variables and Scope (2025-2033)
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID-19 Impact on Biotechnology Reagents & Kits Market (2025-2033)
5.1. COVID-19 Landscape: Biotechnology Reagents & Kits Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends (2025-2033)
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape (2025-2033)
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Biotechnology Reagents & Kits Market, By Kits Type (2025-2033)
8.1. Biotechnology Reagents & Kits Market, by Kits Type
8.1.1. Purification Kits
8.1.1.1. Market Revenue and Forecast
8.1.2. Amplification Kits
8.1.2.1. Market Revenue and Forecast
8.1.3. Detection Kits
8.1.3.1. Market Revenue and Forecast
8.1.4. Isolation Kits
8.1.4.1. Market Revenue and Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Forecast
Chapter 9. Global Biotechnology Reagents & Kits Market, By Technology Type (2025-2033)
9.1. Biotechnology Reagents & Kits Market, by Technology Type
9.1.1. LAMP Technology
9.1.1.1. Market Revenue and Forecast
9.1.2. PCR
9.1.2.1. Market Revenue and Forecast
9.1.3. Cell Culture
9.1.3.1. Market Revenue and Forecast
9.1.4. Sequencing
9.1.4.1. Market Revenue and Forecast
9.1.5. Chromatography
9.1.5.1. Market Revenue and Forecast
9.1.6. Electrophoresis
9.1.6.1. Market Revenue and Forecast
9.1.7. Flow Cytometry
9.1.7.1. Market Revenue and Forecast
Chapter 10. Global Biotechnology Reagents & Kits Market, By Tested Parameters Type (2025-2033)
10.1. Biotechnology Reagents & Kits Market, by Tested Parameters Type
10.1.1. DNA
10.1.1.1. Market Revenue and Forecast
10.1.2. RNA
10.1.2.1. Market Revenue and Forecast
10.1.3. Enzymes
10.1.3.1. Market Revenue and Forecast
10.1.4. Proteins
10.1.4.1. Market Revenue and Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Forecast
Chapter 11. Global Biotechnology Reagents & Kits Market, By Purpose (2025-2033)
11.1. Biotechnology Reagents & Kits Market, By Purpose
11.1.1. On-Site
11.1.1.1. Market Revenue and Forecast
11.1.2. Laboratory
Chapter 12. Global Biotechnology Reagents & Kits Market, By End-Use (2025-2033)
12.1. Biotechnology Reagents & Kits Market, By End-Use
12.1.1. Healthcare
12.1.1.1. Market Revenue and Forecast
12.1.2. Food & Agriculture
12.1.2.1. Market Revenue and Forecast
12.1.3. Natural Resources & Environment
12.1.3.1. Market Revenue and Forecast
12.1.4. Industrial Processing
12.1.4.1. Market Revenue and Forecast
12.1.5. Others
12.1.5.1. Market Revenue and Forecast
Chapter 13. Global Biotechnology Reagents & Kits Market, Regional Estimates and Trend Forecast (2025-2033)
13.1. North America
13.1.1. Market Revenue and Forecast, by Kits
13.1.2. Market Revenue and Forecast, by Purpose
13.1.3. Market Revenue and Forecast, by Technology
13.1.4. Market Revenue and Forecast, by Tested Parameters
13.1.5. Market Revenue and Forecast, by End User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Kits
13.1.6.2. Market Revenue and Forecast, by Purpose
13.1.6.3. Market Revenue and Forecast, by Technology
13.1.6.4. Market Revenue and Forecast, by Tested Parameters
13.1.7. Market Revenue and Forecast, by End User
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Kits
13.1.8.2. Market Revenue and Forecast, by Purpose
13.1.8.3. Market Revenue and Forecast, by Technology
13.1.8.4. Market Revenue and Forecast, by Tested Parameters
13.1.8.5. Market Revenue and Forecast, by End User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Kits
13.2.2. Market Revenue and Forecast, by Purpose
13.2.3. Market Revenue and Forecast, by Technology
13.2.4. Market Revenue and Forecast, by Tested Parameters
13.2.5. Market Revenue and Forecast, by End User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Kits
13.2.6.2. Market Revenue and Forecast, by Purpose
13.2.6.3. Market Revenue and Forecast, by Technology
13.2.7. Market Revenue and Forecast, by Tested Parameters
13.2.8. Market Revenue and Forecast, by End User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Kits
13.2.9.2. Market Revenue and Forecast, by Purpose
13.2.9.3. Market Revenue and Forecast, by Technology
13.2.10. Market Revenue and Forecast, by Tested Parameters
13.2.11. Market Revenue and Forecast, by End User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Kits
13.2.12.2. Market Revenue and Forecast, by Purpose
13.2.12.3. Market Revenue and Forecast, by Technology
13.2.12.4. Market Revenue and Forecast, by Tested Parameters
13.2.13. Market Revenue and Forecast, by End User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Kits
13.2.14.2. Market Revenue and Forecast, by Purpose
13.2.14.3. Market Revenue and Forecast, by Technology
13.2.14.4. Market Revenue and Forecast, by Tested Parameters
13.2.15. Market Revenue and Forecast, by End User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Kits
13.3.2. Market Revenue and Forecast, by Purpose
13.3.3. Market Revenue and Forecast, by Technology
13.3.4. Market Revenue and Forecast, by Tested Parameters
13.3.5. Market Revenue and Forecast, by End User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Kits
13.3.6.2. Market Revenue and Forecast, by Purpose
13.3.6.3. Market Revenue and Forecast, by Technology
13.3.6.4. Market Revenue and Forecast, by Tested Parameters
13.3.7. Market Revenue and Forecast, by End User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Kits
13.3.8.2. Market Revenue and Forecast, by Purpose
13.3.8.3. Market Revenue and Forecast, by Technology
13.3.8.4. Market Revenue and Forecast, by Tested Parameters
13.3.9. Market Revenue and Forecast, by End User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Kits
13.3.10.2. Market Revenue and Forecast, by Purpose
13.3.10.3. Market Revenue and Forecast, by Technology
13.3.10.4. Market Revenue and Forecast, by Tested Parameters
13.3.10.5. Market Revenue and Forecast, by End User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Kits
13.3.11.2. Market Revenue and Forecast, by Purpose
13.3.11.3. Market Revenue and Forecast, by Technology
13.3.11.4. Market Revenue and Forecast, by Tested Parameters
13.3.11.5. Market Revenue and Forecast, by End User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Kits
13.4.2. Market Revenue and Forecast, by Purpose
13.4.3. Market Revenue and Forecast, by Technology
13.4.4. Market Revenue and Forecast, by Tested Parameters
13.4.5. Market Revenue and Forecast, by End User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Kits
13.4.6.2. Market Revenue and Forecast, by Purpose
13.4.6.3. Market Revenue and Forecast, by Technology
13.4.6.4. Market Revenue and Forecast, by Tested Parameters
13.4.7. Market Revenue and Forecast, by End User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Kits
13.4.8.2. Market Revenue and Forecast, by Purpose
13.4.8.3. Market Revenue and Forecast, by Technology
13.4.8.4. Market Revenue and Forecast, by Tested Parameters
13.4.9. Market Revenue and Forecast, by End User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Kits
13.4.10.2. Market Revenue and Forecast, by Purpose
13.4.10.3. Market Revenue and Forecast, by Technology
13.4.10.4. Market Revenue and Forecast, by Tested Parameters
13.4.10.5. Market Revenue and Forecast, by End User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Kits
13.4.11.2. Market Revenue and Forecast, by Purpose
13.4.11.3. Market Revenue and Forecast, by Technology
13.4.11.4. Market Revenue and Forecast, by Tested Parameters
13.4.11.5. Market Revenue and Forecast, by End User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Kits
13.5.2. Market Revenue and Forecast, by Purpose
13.5.3. Market Revenue and Forecast, by Technology
13.5.4. Market Revenue and Forecast, by Tested Parameters
13.5.5. Market Revenue and Forecast, by End User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Kits
13.5.6.2. Market Revenue and Forecast, by Purpose
13.5.6.3. Market Revenue and Forecast, by Technology
13.5.6.4. Market Revenue and Forecast, by Tested Parameters
13.5.7. Market Revenue and Forecast, by End User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Kits
13.5.8.2. Market Revenue and Forecast, by Purpose
13.5.8.3. Market Revenue and Forecast, by Technology
13.5.8.4. Market Revenue and Forecast, by Tested Parameters
13.5.8.5. Market Revenue and Forecast, by End User
Chapter 14. Company Profiles (2025-2033)
14.1. Agilent Technologies
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Becton, Dickinson, and Company
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Bio-Rad Laboratories, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Bio-Techne Corporation
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Cytek Biosciences, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. F. Hoffman-La Roche, Ltd.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Illumina, Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Lonza Group AG
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Merck KGaA
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Molecular Designs
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
14.11. NeoDx Biotech Labs
14.11.1. Company Overview
14.11.2. Product Offerings
14.11.3. Financial Performance
14.11.4. Recent Initiatives
14.12. Promega Corporation
14.12.1. Company Overview
14.12.2. Product Offerings
14.12.3. Financial Performance
14.12.4. Recent Initiatives
14.13. Qiagen
14.13.1. Company Overview
14.13.2. Product Offerings
14.13.3. Financial Performance
14.13.4. Recent Initiatives
14.14. Sartorius
14.14.1. Company Overview
14.14.2. Product Offerings
14.14.3. Financial Performance
14.14.4. Recent Initiatives
14.15. Takara Bio, Inc.
14.15.1. Company Overview
14.15.2. Product Offerings
14.15.3. Financial Performance
14.15.4. Recent Initiatives
14.16. Thermo Fisher Scientific
14.16.1. Company Overview
14.16.2. Product Offerings
14.16.3. Financial Performance
14.16.4. Recent Initiatives
Chapter 15. Research Methodology (2025-2033)
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix (2025-2033)
16.1. About Us
16.2. Glossary of Terms
著作権 ©2022 無断複写・転載を禁じます
